EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Warfarin (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Stroke; Thromboembolism
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms EU-PACT-Warfarin; EUPACT-Warfarin
- 03 Dec 2014 Biomarkers information updated
- 12 Apr 2013 Accrual to date is 101% according to United Kingdom Clinical Research Network.
- 21 Feb 2013 New trial record